Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar;46(3-4):385-407.
doi: 10.1007/s10295-018-02120-y. Epub 2019 Jan 18.

Bioactive molecules from Nocardia: diversity, bioactivities and biosynthesis

Affiliations
Review

Bioactive molecules from Nocardia: diversity, bioactivities and biosynthesis

Dipesh Dhakal et al. J Ind Microbiol Biotechnol. 2019 Mar.

Abstract

Nocardia spp. are catalase positive, aerobic, and non-motile Gram-positive filamentous bacteria. Many Nocarida spp. have been reported as unusual causes of diverse clinical diseases in both humans and animals. Therefore, they have been studied for a long time, primarily focusing on strain characterization, taxonomic classification of new isolates, and host pathophysiology. Currently, there are emerging interests in isolating bioactive molecules from diverse actinobacteria including Nocardia spp. and studying their biosynthetic mechanisms. In addition, these species possess significant metabolic capacity, which has been utilized for generating diverse functionalized bioactive molecules by whole cell biotransformation. This review summarizes the structural diversity and biological activities of compounds biosynthesized or biotransformed by Nocardia spp. Furthermore, the recent advances on biosynthetic mechanisms and genetic engineering approaches for enhanced production or structural/functional modification are presented.

Keywords: Bioactive compounds; Biosynthetic mechanism; Biotransformation; Nocardia spp.; Structural modifications.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Antibiot (Tokyo). 1999 Feb;52(2):201-2 - PubMed
    1. J Antibiot (Tokyo). 1999 Mar;52(3):245-55 - PubMed
    1. J Clin Microbiol. 2000 Jan;38(1):158-64 - PubMed
    1. Biotechnol Bioeng. 2000 Mar 20;67(6):714-9 - PubMed
    1. J Antibiot (Tokyo). 2000 Jan;53(1):70-4 - PubMed

LinkOut - more resources